![]() |
Volumn 33, Issue 5, 2015, Pages 338-341
|
Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
a,b
c
HOSPITAL CLÍNIC
(Spain)
|
Author keywords
Carbapenemases; Extended spectrum beta lactamase; Guidelines; Multidrug resistant Enterobacteriaceae; Therapy
|
Indexed keywords
AMINOGLYCOSIDE;
ANTIINFECTIVE AGENT;
AZTREONAM;
CEPHALOSPORIN DERIVATIVE;
COLISTIN;
FOSFOMYCIN;
TIGECYCLINE;
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMOXICILLIN PLUS CLAVULANIC ACID;
ANTIBIOTIC AGENT;
BETA LACTAMASE INHIBITOR;
CARBAPENEM;
CARBAPENEMASE;
CEFEPIME;
CEFOTAXIME;
CEFTAZIDIME;
CEPHAMYCIN;
COTRIMOXAZOLE;
ERTAPENEM;
EXTENDED SPECTRUM BETA LACTAMASE;
IMIPENEM;
MEROPENEM;
PIPERACILLIN PLUS TAZOBACTAM;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TEMOCILLIN;
ANTIMICROBIAL THERAPY;
ARTICLE;
BACTERIUM DETECTION;
CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE;
DISK DIFFUSION;
ENTEROBACTERIACEAE INFECTION;
EVIDENCE BASED PRACTICE;
EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE;
HUMAN;
MULTIDRUG RESISTANT ENTEROBACTERIACEAE INFECTION;
PRACTICE GUIDELINE;
ANTIBIOTIC SENSITIVITY;
ANTIBIOTIC THERAPY;
BACTERIUM CULTURE;
BILIARY TRACT INFECTION;
ENTEROBACTERIACEAE;
EPSILOMETER TEST;
EVIDENCE BASED MEDICINE;
INDIVIDUALIZATION;
LOADING DRUG DOSE;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
METHODOLOGY;
MICROBIOLOGICAL EXAMINATION;
MINIMUM INHIBITORY CONCENTRATION;
MULTIDRUG RESISTANCE;
NONHUMAN;
OBSERVATIONAL STUDY;
PATIENT CARE;
PATIENT MONITORING;
PUBLIC HEALTH PROBLEM;
RECOMMENDED DRUG DOSE;
SPAIN;
URINARY TRACT INFECTION;
DRUG EFFECTS;
ENTEROBACTERIACEAE INFECTIONS;
ANTI-INFECTIVE AGENTS;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
ENTEROBACTERIACEAE;
ENTEROBACTERIACEAE INFECTIONS;
HUMANS;
|
EID: 84929515720
PISSN: 0213005X
EISSN: 15781852
Source Type: Journal
DOI: 10.1016/j.eimc.2014.11.015 Document Type: Article |
Times cited : (16)
|
References (1)
|